Alberto Conde‐Taboada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alberto Conde‐Taboada has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
Eduardo López‐Bran
Dermatology Department, Hospital Universitario Clínico San Carlos Complutense University of Madrid Madrid Spain
5 shared publications- Elena González-Guerra
Departamento de Dermatología, Hospital Clínico San Carlos, Madrid, Spain
5 shared publications - Álvaro Iglesias-Puzas
Servicio de Dermatología, Hospital Universitario Clínico San Carlos, Madrid, España
5 shared publications Eduardo López-Bran
Dermatology Department, Hospital Clínico San Carlos, Madrid, Spain
4 shared publicationsBeatriz Aranegui‐Arteaga
Dermatology Department Hospital Universitario Infanta Cristina Madrid Spain
3 shared publications- Eduardo López Bran
Dermatology Department, Hospital Clínico San Carlos, Madrid, Spain
3 shared publications
Latest Publications
- 30 June 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (1) , 181-183
Adolescent With Penile Lesions
- 30 June 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (1) , 181-183
Adolescent With Penile Lesions
- 4 June 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (11) , 2143-2145
Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real‐World Cohort
- 4 June 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (11) , 2143-2145
Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real‐World Cohort
- Open Access
- 1 December 2023
- Published by Elsevier in Nefrología (English Edition)
- Vol. 43, 114-116
Influenza vaccine-induced leukocytoclastic vasculitis in a patient with a transplanted kidney
- 1 December 2023
- Published by Elsevier in Nefrología (English Edition)
- Vol. 43, 114-116
Open AccessInfluenza vaccine-induced leukocytoclastic vasculitis in a patient with a transplanted kidney
- Open Access
- 1 September 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 98 (5) , 696-698
Dermatologistas podem ser os primeiros a suspeitar de leiomiomatose hereditária e carcinoma de células renais
- 1 September 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 98 (5) , 696-698
Open AccessDermatologistas podem ser os primeiros a suspeitar de leiomiomatose hereditária e carcinoma de células renais
- Open Access
- 23 May 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (5) , 696-698
Dermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome
- 23 May 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (5) , 696-698
Open AccessDermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome
- 9 May 2023
- Vol. 21 (2) , 131-138
Bariatric Surgery for Patients with Obesity May Also Help Their Psoriasis.
- 9 May 2023
- Vol. 21 (2) , 131-138
Bariatric Surgery for Patients with Obesity May Also Help Their Psoriasis.
- Open Access
- 18 August 2022
- Published by Elsevier in Nefrología
- Vol. 43, 113-115
Vasculitis leucocitoclástica por vacuna de la influenza en un paciente trasplantado renal
- 18 August 2022
- Published by Elsevier in Nefrología
- Vol. 43, 113-115
Open AccessVasculitis leucocitoclástica por vacuna de la influenza en un paciente trasplantado renal
- 29 July 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (4) , E312-E319
Fear of cancer recurrence in patients with non‐metastatic melanoma: Spanish validation and disease‐related factors
Introduction: It is essential for clinicians to understand the phenomenon of fear of cancer recurrence (FCR) in order to understand the psychological impact it has on patients with melanoma.Objectives: To validate an FCR questionnaire in Spanish for patients with non‐metastatic melanoma and to describe the clinical and demographic variables associated with FCR in these patients.Methods: Patients diagnosed with non‐metastatic melanoma were selected. The questionnaire was translated and adapted to Spanish following international guidelines. The internal consistency, construct validity, and temporal stability of the questionnaire were analysed using Cronbach's alpha, confirmatory factor analysis, and test–retest reliability, respectively. Following this, the correlation between FCR scores and the study variables was evaluated.Results: A total of 123 patients were included in the study. The translated and adapted questionnaire showed high reliability (overall Cronbach's alpha 0.834), temporal stability (intraclass correlation coefficient 0.8), and unidimensionality. The mean FCR score was 16.1 ± 6.7. The highest FCR scores were observed in women and young patients (p < 0.01). Patients with a personal history of cancer, facial melanoma, or skin graft reconstruction also obtained a high FCR score (p < 0.05). No differences were found between FCR and other tumour characteristics, such as the Breslow index or the time since diagnosis.Conclusions: This validated questionnaire is suitable for evaluating FCR. We also identified factors that tend to increase FCR scores, thus allowing clinicians to identify patients at risk and start preventive measures.
- 29 July 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (4) , E312-E319
Fear of cancer recurrence in patients with non‐metastatic melanoma: Spanish validation and disease‐related factors
Introduction: It is essential for clinicians to understand the phenomenon of fear of cancer recurrence (FCR) in order to understand the psychological impact it has on patients with melanoma.Objectives: To validate an FCR questionnaire in Spanish for patients with non‐metastatic melanoma and to describe the clinical and demographic variables associated with FCR in these patients.Methods: Patients diagnosed with non‐metastatic melanoma were selected. The questionnaire was translated and adapted to Spanish following international guidelines. The internal consistency, construct validity, and temporal stability of the questionnaire were analysed using Cronbach's alpha, confirmatory factor analysis, and test–retest reliability, respectively. Following this, the correlation between FCR scores and the study variables was evaluated.Results: A total of 123 patients were included in the study. The translated and adapted questionnaire showed high reliability (overall Cronbach's alpha 0.834), temporal stability (intraclass correlation coefficient 0.8), and unidimensionality. The mean FCR score was 16.1 ± 6.7. The highest FCR scores were observed in women and young patients (p < 0.01). Patients with a personal history of cancer, facial melanoma, or skin graft reconstruction also obtained a high FCR score (p < 0.05). No differences were found between FCR and other tumour characteristics, such as the Breslow index or the time since diagnosis.Conclusions: This validated questionnaire is suitable for evaluating FCR. We also identified factors that tend to increase FCR scores, thus allowing clinicians to identify patients at risk and start preventive measures.
- Open Access
- 23 November 2021
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (3) , 578-580
Influence of COVID‐19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital
The COVID-19 pandemic required people to be confined to their homes and disrupted normal hospital activities. We examine whether this lock-down generated changes in the size of the tumours. The dimensions of the surgically removed malignant skin tumours from the first 150 patients treated after the confinement ended in Spain (22nd May 2020) were compared with those of the last 150 patients to receive such treatment before the confinement began (13th March, 2020). Tumour surface area results were collected from pathology reports. Overall, no significant difference was seen in the tumour sizes. However, among men, the tumours removed post-confinement were significantly larger (p<0.05). Controversy exists over how the reduction in the number of tumours diagnosed during lock-downs might influence the characteristics of tumours. In the present work, no overall difference was seen in the size of the tumours removed, although those removed from men post-confinement were larger.
- 23 November 2021
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (3) , 578-580
Open AccessInfluence of COVID‐19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital
The COVID-19 pandemic required people to be confined to their homes and disrupted normal hospital activities. We examine whether this lock-down generated changes in the size of the tumours. The dimensions of the surgically removed malignant skin tumours from the first 150 patients treated after the confinement ended in Spain (22nd May 2020) were compared with those of the last 150 patients to receive such treatment before the confinement began (13th March, 2020). Tumour surface area results were collected from pathology reports. Overall, no significant difference was seen in the tumour sizes. However, among men, the tumours removed post-confinement were significantly larger (p<0.05). Controversy exists over how the reduction in the number of tumours diagnosed during lock-downs might influence the characteristics of tumours. In the present work, no overall difference was seen in the size of the tumours removed, although those removed from men post-confinement were larger.